We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
-12.28%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$334B
AUM Growth
-$65.4B
Cap. Flow
-$11.7B
Cap. Flow %
-3.51%
Top 10 Hldgs %
13.97%
Holding
7,016
New
146
Increased
2,663
Reduced
3,412
Closed
209

Sector Composition

Rank Sector Weight
1 Technology 12.53%
2 Healthcare 10.36%
3 Financials 9.14%
4 Consumer Discretionary 7.65%
5 Communication Services 7.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FEDU
6226
Four Seasons Education Depositary Shares Rep 10 Ordinary Shares
FEDU
$18.2M
$2K ﹤0.01%
40
FLGT icon
6227
Fulgent Genetics
FLGT
$483M
$2K ﹤0.01%
510
-1,490
-75% -$5.23K
GSIT icon
6228
GSI Technology
GSIT
$220M
$2K ﹤0.01%
404
GURE
6229
Gulf Resources
GURE
$4.53M
$2K ﹤0.01%
60
-201
-77% -$8.82K
HEPA
6230
DELISTED
Hepion Pharmaceuticals
HEPA
0
HWBK icon
6231
Hawthorn Bancshares
HWBK
$267M
$2K ﹤0.01%
92
-914
-91% -$17.2K
ICVT icon
6232
iShares Convertible Bond ETF
ICVT
$7.22B
$2K ﹤0.01%
45
IMNN icon
6233
Imunon
IMNN
$6.68M
$2K ﹤0.01%
4
+1
+33% +$415
IVAL icon
6234
Alpha Architect International Quantitative Value ETF
IVAL
$221M
$2K ﹤0.01%
65
KPRX icon
6235
Kiora Pharmaceuticals
KPRX
$11.5M
$2K ﹤0.01%
1
MTNB icon
6236
Matinas BioPharma
MTNB
$1.9M
$2K ﹤0.01%
40
MYO icon
6237
Myomo
MYO
$38.6M
$2K ﹤0.01%
49
NDRA icon
6238
ENDRA Life Sciences
NDRA
$5.77M
0
NEON icon
6239
Neonode
NEON
$14.2M
$2K ﹤0.01%
+1,500
New +$3.25K
NNDM
6240
Nano Dimension
NNDM
$320M
$2K ﹤0.01%
217
+7
+3% +$116
PHIO icon
6241
Phio Pharmaceuticals
PHIO
$11.6M
$2K ﹤0.01%
1
PPBT
6242
Purple Biotech
PPBT
$1.29M
$2K ﹤0.01%
1
-1
-50% -$2.52K
PW
6243
Power REIT
PW
$3.14M
$2K ﹤0.01%
28
QUIK icon
6244
QuickLogic
QUIK
$236M
$2K ﹤0.01%
144
+73
+103% +$940
REK icon
6245
ProShares Short Real Estate
REK
$11.7M
$2K ﹤0.01%
+67
New +$2.13K
RELL icon
6246
Richardson Electronics
RELL
$271M
$2K ﹤0.01%
+247
New +$1.87K
SACH
6247
Sachem Capital Corp
SACH
$39.4M
$2K ﹤0.01%
452
-448
-50% -$1.84K
SCNI
6248
Scinai Immunotherapeutics
SCNI
$1.36M
$2K ﹤0.01%
5
SEED icon
6249
Origin Agritech
SEED
$12.1M
$2K ﹤0.01%
+499
New +$3.37K
SNFCA icon
6250
Security National Financial
SNFCA
$243M
$2K ﹤0.01%
468
+29
+7% +$107

Similar funds

Morgan Stanley's Q4 2018 Portfolio in Review

As of Q4 2018, Morgan Stanley held 7,016 positions worth $334B, down 16% from $400B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Morgan Stanley withdrew a net $11.7B in Q4 2018, closing 209 positions and reducing 3,412 holdings. Its most notable exit was Praxair Inc, an estimated $398M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Morgan Stanley opened a new position in Linde worth $342M.

  • Morgan Stanley's largest Q4 2018 buy was Linde: 2,188,871 shares worth $342M.
  • Morgan Stanley added most to People Inc in Q4 2018, an estimated $558M increase.
  • Morgan Stanley's biggest Q4 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
  • Morgan Stanley fully exited Praxair Inc in Q4 2018, selling an estimated $398M.
  • Morgan Stanley's ten largest holdings make up 14% of its $334B portfolio in Q4 2018.
  • Morgan Stanley opened 146 new positions and closed 209 in Q4 2018.
  • Morgan Stanley's portfolio value fell 16% quarter-over-quarter to $334B.

Based on Morgan Stanley's 13F filing for Q4 2018, filed 14 Feb 2019.